Aleksander Peterc, an analyst from Bernstein, reiterated the Buy rating on Exosens (EXENS – Research Report). The associated price target is €45.50.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Aleksander Peterc has given his Buy rating due to a combination of factors including Exosens’ strategic expansion plans and strong financial outlook. The company announced an increase in manufacturing capacity, both in Europe and for the first time in the US, which is expected to meet the growing global demand and open new market opportunities, particularly with the US Department of Defense.
Exosens aims to capture a larger share of the US market by establishing local manufacturing facilities, which could significantly boost its Amplification revenue. The anticipated market share gains and increased revenue projections have led to an upward revision of Exosens’ future earnings estimates, enhancing its valuation. Consequently, Exosens’ stock has been added to Bernstein’s Top 10 European SMID selection, reinforcing the Buy rating with a price target of €45.5.
According to TipRanks, Peterc is ranked #3955 out of 9384 analysts.
In another report released on March 13, Stifel Nicolaus also maintained a Buy rating on the stock with a €38.00 price target.